1. The EGFR-specific tyrosine kinase inhibitor, ZD1839 (IRESSA™) is efficacious following oral administration against EGFR-overexpressing intracranial tumors;Archer;Neuro-oncol,2000
2. A randomized phase II trial of high dose alkylating agents plus VP-16 in children with high grade astrocytoma;Arenson;J Pediatr Hematol Oncol,1999
3. Supratentorial glioblastoma in children: a series of 27 surgically treated cases;Artico;Childs Nerv Syst,1993
4. Neurophysiological monitoring during astrocytoma surgery;Berger;Neurosurg Clin North Am,1990
5. When is a high-grade astrocytoma (HGA) not a HGA? Results of a central review of 226 cases of anaplastic astrocytoma (AA), glioblastoma multiforme (GBM), and other-HGA (OTH-HGA) by five neuropathologists;Boyett;Proc Am Soc Clin Oncol,1998